New Balance will donate 10 percent of the shoe’s suggested retail price to support rare cancer research led by Memorial Sloan Kettering Cancer Center

NEW YORKDec. 1, 2017 /PRNewswire/ — Starting today, New Balance will introduce the Cycle for Survival WX09 NBCycle shoe as part of its line of premier athletic gear. The exclusive indoor cycling shoe benefits rare cancer research and features orange design accents as a tribute to the Cycle for Survival community of patients, survivors, doctors, caregivers and supporters fighting back against rare cancers.

Beginning December 1, 2017, New Balance will donate 10 percent of the suggested retail price for each Cycle for Survival WX09 NBCycle shoe exclusively sold on newbalance.com to Memorial Sloan Kettering Cancer Center (MSK). Cycle for Survival, owned and operated by MSK, is the movement to beat rare cancers. 100 percent of every dollar donated to Cycle for Survival goes directly to groundbreaking rare cancer research.

At a suggested retail price of $124.99, the Cycle for Survival WX09 NBCycle is made of a breathable mesh upper and NBFresh lining, to help resist odor. The adjustable mid-foot strap allows for maximum comfort, while the full-length midsole supports power transfer during cycling. The shoe is extremely versatile: a unique design that is walkable to and from the cycling studio. The Cycle for Survival WX09 NBCycle is available in women’s sizes 5 through 12 and is compatible with SPD® cycling cleats.

Cycle for Survival has raised more than $140 million since it was founded in 2007, with $110 millionraised in the past four years. More than 34,000 participants and 230,000 donors are expected to support Cycle for Survival’s indoor team cycling events in 2018. Instructors from Equinox, Cycle for Survival’s founding partner, will lead the annual rides in January, February and March in 16 cities across the country. For more information about Cycle for Survival, please visit www.cycleforsurvival.org.

MORE INFORMATION

About Cycle for Survival
Join the Battle. Cycle for Survival is the movement to beat rare cancers. Since 2007, Cycle for Survival has raised $140 million through its signature indoor team cycling events across the United States to help fund pioneering rare cancer research led by Memorial Sloan Kettering Cancer Center, which owns and operates Cycle for Survival. 100 percent of every donation funds rare cancer research. About half of all cancer patients are fighting a rare cancer, and they often face limited or no treatment options. Together with the movement’s founding partner, Equinox, Cycle for Survival has supported innovative clinical trials, research studies and major scientific initiatives. For a list of events, research updates and additional information, visit https://www.cycleforsurvival.org and follow Cycle for Survival on FacebookTwitterInstagram, and YouTube.